skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Team,
A couple different parts to this question. The "Geno" sector has exploded this year. Different hot names in the sector seem to be moving 10-20% daily. I have buddies now piling into these names now, so am wondering if maybey there's a "top" coming here soon? Or if you think this Euphoria will continue in the sector? To me it almost feels like gambling to try to buy in to these things right now. Also on this topic, can you briefly give your thoughts on what has made the Geno sector suddenly start to move this year? Its not like geno work is a new thing...or is it just hitting some major progress this year? Same can be said for the EV sector. For fear of "missing out" I am tempted to sell KXS out of my rsp for a slight gain as I hold this name in 2 different accounts to raise funds to buy EAGB (the canadian version of ARKG). My portfolio is currently heavy weighted tech and I currently have no Geno exposure. Is EAGB the best way for me to play this sector long term, or do you have any explosive individual GENO names you would recommend buying for a multi bagger possibility? I have heard BNGO has some good things coming its way? .....Or should I wait for a pullback in the massive run up before I think about doing this...or not at all? If I did buy EAGB I would probably buy and hold it for years as a way to play the sector. It does seem like there could be some major breakthroughs down the road in geno technology.
Read Answer Asked by Shane on January 15, 2021
Q: Hi Peter and Staff

FInally bite the bullet on Sienna, looking to redeploy in the US topping up some or all of my US basket of health care. Please eliminate any of the above that you do not feel are a buy at this time and rank the rest within categories of strong buy, buy or hold.
Thanks for all you do
Dennis
Read Answer Asked by Dennis on January 14, 2021
Q: Hi Peter,
The market did not take kindly to the revenue guidance for 2021 even if the growth rate would be 20%? Were the expectations from Europe much higher than what the company expects? What is your view? With its current valuation and projected growth, would you expect the stock price to stagnate? Unless they promise low and deliver over?
Read Answer Asked by Rajiv on January 14, 2021
Q: After TH ore-announced, they immediately announced a bought deal at a discount to market. It doesn’t appear that they are imminent need of cash, so I’m curious why they wouldn’t wait for a higher price if they felt their shares were under valued. I’d be curious your thoughts on this. Is it ever necessary to do a deal like this to increase market awareness? Thanks.
Read Answer Asked by Brian on January 14, 2021
Q: Good morning 5i team!

I am considerably underweight in healthcare stocks. I do own Well, and I have considered Doc. I was wondering your thoughts on Personalis as I do not see any questions relating to this company. Thank you for your great service.
Read Answer Asked by Meghan on January 14, 2021
Q: Seasons Greetings, to you all,
In order to start my TFSA year of right can I get your opinion on a few of each Cdn. & U.S. stocks that may be considered MUST OWN in the Materials & Health sectors.
Also an alternate on ETF's?
Thanks for your usual good answers!
Read Answer Asked by Terry on January 12, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!